2014
DOI: 10.3390/molecules19056651
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Cytotoxicity and Mechanistic Evaluation of 4-Oxoquinoline-3-carboxamide Derivatives: Finding New Potential Anticancer Drugs

Abstract: As part of a continuing search for new potential anticancer candidates, we describe the synthesis, cytotoxicity and mechanistic evaluation of a series of 4-oxoquinoline-3-carboxamide derivatives as novel anticancer agents. The inhibitory activity of compounds 10-18 was determined against three cancer cell lines using the MTT colorimetric assay. The screening revealed that derivatives 16b and 17b exhibited significant cytotoxic activity against the gastric cancer cell line but was not active against a normal ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 27 publications
0
7
0
3
Order By: Relevance
“…[13] Encouragingly, the addition of an external base [e.g., Et 3 N, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), and 1,5-diazabicyclo[4.3.0]non-5-ene (DBN)] resulted in desired 4-quinolone-3-carboxylic acid amide 3 along with compound 2 (Scheme 2, Entries 2-4), which is in agreement with literature data. [14] On doubling the amount of base (Scheme 2, Entry 5), the desired product ratio was increased. To our delight, ozonolysis in a mixture of CH 2 Cl 2 /MeOH (5:1) under similar conditions improved the yield (58 %; Scheme 2, Entry 7).…”
Section: Resultsmentioning
confidence: 99%
“…[13] Encouragingly, the addition of an external base [e.g., Et 3 N, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), and 1,5-diazabicyclo[4.3.0]non-5-ene (DBN)] resulted in desired 4-quinolone-3-carboxylic acid amide 3 along with compound 2 (Scheme 2, Entries 2-4), which is in agreement with literature data. [14] On doubling the amount of base (Scheme 2, Entry 5), the desired product ratio was increased. To our delight, ozonolysis in a mixture of CH 2 Cl 2 /MeOH (5:1) under similar conditions improved the yield (58 %; Scheme 2, Entry 7).…”
Section: Resultsmentioning
confidence: 99%
“…Após incubação à temperatura ambiente por 1 hora e centrifugação o sobrenadante foi removido, e a hemoglobina liberada foi medida espectrofotometricamente a 540 nm. DMSO era usado como controle negativo, e Triton X-100 (1%) foi usado como controle positivo [13].…”
Section: Atividade Hemolítica Em Eritrócitos De Camundongounclassified
“…O metabólito S1, apresentou-se como um sólido amarelo claro e solúvel em piridina, sua estrutura foi determinada com base na análise dos espectros de RMN 1 H, 13 De acordo com o espectro de RMN 13 C da substância S1, foi observado a presença de 21 carbonos, valor este igual ao número de carbono presente na estrutura, dentre eles seis carbonos metínicos (CH), três metílicos (CH3) e onze não hidrogenados. O sinal mais desblindado em 181,5 ppm atribuído ao carbono carbonílico (C-4), os sinais em δC 161,3 (C-7), 160,1 (C-5), 155,8 (C-9), 149,2 (C-4') e 148,4 (C-3') foram atribuídos aos cinco átomos de carbono aromáticos oxigenados (Figura 4).…”
Section: S5unclassified
See 1 more Smart Citation
“…Even though the antibacterial profile has been the most common bioactivity associated with this class of substances [1], other types of pharmacological activities have also been explored and were successfully described by researchers around the world [34], such as antiviral [56], antiplasmoidal [78], anticancer [910], and trypanocide [11] activities. 4-Oxoquinoline-3-carboxamide derivatives, more specifically, have shown to be a promising structural scaffold for pharmacological profiles [1222]. For example, Pasquini and co-workers have studied the application of N -adamantyl-4-oxoquinoline-3-carboxamide derivative 1 as selective cannabinoid type 2 receptor ligand with agonistic effect for analgesic response [13].…”
Section: Introductionmentioning
confidence: 99%